logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Conglin Technology: Net profit in the first half of 2025 decreased by 89.23% year-on-year.

date
21/08/2025
SungLin Technology announces that the operating income in the first half of 2025 was 256 million yuan, a year-on-year decrease of 11.08%. The net profit was 5.6835 million yuan, a year-on-year decrease of 89.23%.
Latest
1 m ago
Meike Lancome (600882.SH) released its first half-year financial results, with a net profit attributable to the parent company of 133 million yuan, an increase of 86.27% year-on-year.
2 m ago
Senzer Pharmaceuticals (02096.HK) plans to repurchase shares.
2 m ago
Google (GOOGL.US) search engine AI mode will be open to the global public.
3 m ago
New stock news | Tiantian Biomedical Pharmaceuticals submitted an application to the Hong Kong Stock Exchange to independently develop innovative drugs for allergic diseases and autoimmune diseases.
4 m ago
Li Ning distributed a mid-term dividend of 0.3359 yuan per share.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.